WHO 5-Year Strategic Work Plan for Biosafety

Similar documents
World Federation for Culture Collections ICCC-12 Conference Florianopolis, Brazil, 26 Sept 1 Oct Dr Nicoletta Previsani

The WHO laboratory network to enhance laboratory biosafety and biosecurity in developing countries

Biological Weapons Convention Meeting of Experts. Geneva, Switzerland August WHO's. Dr Nicoletta Previsani

ated Support for Jordan

3/15/2017. Predict, Prevent and Prepare: Improving Laboratory Biosafety and Biosecurity Across the Nation. Disclosure Statement.

Development of a draft five-year global strategic plan to improve public health preparedness and response

STRENGTHENING NATIONAL IMPLEMENTATION

GLOBAL HEALTH SECURITY AGENDA: ACTION PACKAGE PREVENT-3 BIOSAFETY AND BIOSECURITY ASSESSMENT

Practical Experience of Implementing New Laboratory Biorisk Standards in Indonesia

The Implementation of Biorisk compliance with International Standard

Iraq Biological Security Grant Competition Project Proposal

Overview of Global Biosafety Tools (Regulations, Guidelines, Assessment Tools) Shanna Nesby-O Dell DVM, MPH September 2015

WHO's response in the case of an alleged use of a biological agent

Assessment of Awareness Level about Bio Risk Management among Staff of Different Academic Laboratories

RISK ASSESSMENT ON HEALTH AND SAFETY: ASEAN EXPERIENCE

International Health Regulations (IHR) Implementation status in the Americas

IHR News The WHO quarterly bulletin on IHR implementation

International Journal of Antimicrobial Agents

No Path? No Problem? Perspectives from a Public Health Laboratory

Joint external evaluation of IHR Core Capacities of the Republic of Uganda. Executive summary June 26-30, 2017

BIOSECURITY IN THE LABORATORY

IHR JOINT EXTERNAL EVALUATION OF TAIWAN

Special session on Ebola. Agenda item 3 25 January The Executive Board,

GUIDELINES FOR INVESTIGATION OF SUSPICIOUS BIOLOGICAL EVENTS. (guidelines for national veterinary services)

Safety Culture in Life Sciences Laboratories: Time for Action. Donald R. Callihan

WHO's response to the Fukushima Daiichi NPP accident (2012) Seminar on the recovery and reconstruction of Fukushima, 3 September 2014, Geneva

3rd Health Programme

Biological Agents and Toxins Act: Development and Enforcement of Biosafety and Biosecurity in Singapore

Joint External Evaluation. of the Democratic Socialist Republic of Sri Lanka. Mission report: June 19-23, 2017

IHR Core Capacities Overview and Monitoring

Ebola Preparedness and Response in Ghana

IHR Implementation in the Western Pacific Region

NLTC-9. Supporting Your Sentinel Laboratories

Risk Assessment for the TB Laboratory

International Collaboration and Partnership in Countering Biological Threats. Presentation by Georgia

Laboratory Assessment Tool

Provisional agenda (annotated)

Biosafety in CDC Laboratories: The Path Forward

Guideline: Administrative & Logistic Arrangement in Supporting The Joint Multi-Sectoral Outbreak Investigation & Response in ASEAN

PHEIC Public Health Event with International Concern

2016 APHL BIOSAFETY AND BIOSECURITY SURVEY

INTERNATIONAL HEALTH REGULATION (IHR) Sumber: Health Security Stewards Fellowship Training Okt 2017

ANNEX H HEALTH AND MEDICAL SERVICES

GLOBAL HEALTH SECURITY AGENDA ROADMAP FOR ETHIOPIA

LAUNCH OF INDUSTRY ENDORSED BIOSAFETY TRAINING STRUCTURE AND FIRST BIOSAFETY PASSPORT IN SINGAPORE

Submission to the OIE for official recognition of FMD country status and endorsement of official control programme

Biosafety and biosecurity as essential pillars of international health security and cross-cutting elements of biological nonproliferation

Extended Biosafety Advisory Group (BAG) meeting Meeting Report

Assuring Laboratory Biosecurity

VIRGINIA TECH INSTITUTIONAL BIOSAFETY COMMITTEE

WHO Health Emergencies Programme (WEP) Global Health Cluster Partner Meeting June 2016, Geneva

WORLD HEALTH ORGANIZATION

HEALTH EMERGENCY MANAGEMENT CAPACITY

DISEASE SURVEILLANCE AND RESPONSE PROGRAMME AREA DISEASE PREVENTION AND CONTROL CLUSTER

2 WHO: World Health Organization 3 ISO: International Organization for Standardization

Ryan Burnette, Ph.D. Director, Alliance Biosciences

CBRN National Action Plans

World Health Organization (WHO)

International Health Regulations

WHO and the IHR(2005) in public health event management in air travel

IHR News. The WHO quarterly bulletin on IHR implementation. 31 March 2009, No. 6

INTERNATIONAL HEALTH REGULATIONS

This document is a preview generated by EVS

2017 APHL BIOSAFETY AND BIOSECURITY SURVEY

CDC/APHL Laboratory Biosafety Competencies for the BSL-2, BSL-3 and BSL-4 Laboratories

Health workforce coordination in emergencies with health consequences

Policy on Minors in Laboratories

International Health Regulations (2005)

TRAINING. A. Hazard Communication/Right-to-Know Training

July 2017 June Maintained by the Bureau of Preparedness & Response Division of Emergency Preparedness and Community Support.

Research Biosafety Committee Terms of Reference

Regulatory Control of Diagnostics in Tanzania. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority

Guidelines for Biosafety in Teaching Laboratories Using Microorganisms

READVERTISED. Call for Proposals

Food Safety Modernization Act

Biosafety and Exposure Control Plan

Public health, innovation and intellectual property: global strategy and plan of action

Governance and Implementation Mechanisms of ASEAN Post-2015 Health Development Agenda

Health Protection Scotland. Protecting Scotland s Health

Evolution of the International Health Regulations. International Health Regulations. The new IHR

Advancing Biosafety Across the U.S. Clinical Laboratory Community

COUNTRY ROADMAP GEORGIA

Regional Alignment in Asia Pacific -

PEPIN COUNTY EMERGENCY SUPPORT FUNCTION (ESF) 8 PUBLIC HEALTH AND MEDICAL

Global Health Engagement U.S. Department of Defense

Emergency contingency planning at designated Points of Entry

ENIVD CODE OF CONDUCT for Outbreak Assistance Laboratories. CHECKLIST of major issues to address before departure and during the mission

WHO s role in strengthening global preparedness to radiological and nuclear emergencies Dr Zhanat CARR Department of Public Health and Environment

ASIA PACIFIC STRATEGY FOR EMERGING DISEASES AND PUBLIC HEALTH EMERGENCIES

Regional Disease Surveillance Systems Enhancement (REDISSE) Project

Joint External Evaluation. of TURKMENISTAN. Mission report: June 2016

JANUARY Evaluation of Impact of CBEP Training Activities on the Performance of Targeted Laboratories in Iraq

ISO INTERNATIONAL STANDARD. Medical laboratories Requirements for safety. Laboratoires de médecine Exigences pour la sécurité

SUPPORT TO COUNTRIES FOR STRENGTHENING PUBLIC HEALTH CAPACITIES REQUIRED UNDER THE INTERNATIONAL HEALTH REGULATIONS

Spread Pack Prototype Version 1

The FDA Food Safety Modernization Act of 2009 Section-by-Section Summary

ASEAN-SAARC-WHO Collaboration for implementation of the HPED Project

Readiness Checklist for Plague V Country: Date:

BOV POLICY # 21 (2016) COMMUNICABLE DISEASE PROTOCOL

Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination

Transcription:

IFBA 1 st International Conference Global Biosafety & Biosecurity: Taking Action Bangkok, Thailand, 15-17 Feb 2011 WHO 5-Year Strategic Work Plan for Biosafety Dr Nicoletta Previsani Laboratory Alliances and Biosafety World Health Organization 1

A Strategic Work Plan for 2010-2014 In the beginning we called it: '193 Ways to Implement Biosafety' 193 Member States And this is how it all began 2

A sad trigger for safety awareness: Laboratory Acquired Infections (LAIs): the risk of sparking an epidemic FMD Pirbright, 2007 Taipei Airport '03 The SARS outbreak was over, the Region was coming out of a huge economic crisis The viruses were still available in laboratories 3 SARS Singapore, 2003 Taipei, 2003 Beijing, 2004 $$$ Strengthen BIOSAFETY! Reduce RISKS of infection! It should not have happened, even in these extraordinary circumstances and it must not happen again Hilary Benn Environment Secretary

4 WHO s public health mandate for biosafety and laboratory biosecurity WHO Constitution of 1948 "Attainment by all people of highest possible levels of health World Health Assembly resolution 55.16 (2002) "Global public health response to natural occurrence, accidental release or deliberate use of biological and chemical agents or radionuclear material that affect health International Health Regulations, resolution 58.3 (2005) "Prevention and control of the international spread of disease and public health risks" World Health Assembly resolution 58.29 (2005) "Enhancement of laboratory biosafety"

International Health Regulations IHR (2005) 194 countries are signatories Purpose: "prevent, protect against, control and provide a public health response to the international spread of disease" Requires countries to develop minimum core national and international surveillance and reporting capacities 5 May 2005 http://www.who.int/csr/ihr/en/index.html

Core capacity requirements for surveillance and response IHR (2005) Annex I 6 Countries shall develop, strengthen and maintain the capacity to prevent, detect, assess, notify and report public health emergencies of international concern respond promptly and efficiently to public health risks and public health emergencies of international concern and provide support for the above through specialized staff laboratory analysis of samples (domestically or through collaborating centres) logistical assistance (equipment, supplies and transport)

Transport and handling of biological substances, reagents and materials for diagnostic purposes Article 46: Countries shall facilitate the transport, entry, exit, processing and disposal of biological substances and diagnostic specimens, reagents and other diagnostic materials for verification and public health response purposes 7

Laboratory support to outbreak response Laboratory capacity needs can be met supranationally Laboratory services are essential to identify and confirm the infectious agents likely to cause public health emergencies of international concern (PHAIC) Clear role and responsibility within national surveillance & response system Quality Assurance Biorisk Management Specimen collection, transfer and transport Laboratory services cannot be switched on just for outbreak investigation WHA 2006: immediate and voluntary compliance with IHR (2005): WHO is requested to "expand and accelerate training efforts in the areas of laboratory capacity, including regional networking of laboratories, biosafety, and quality control " 8

IHR Timeframe 2005 World Health Assembly approved the revised IHR 2007 Entry into force assess existing national structures and resources to meet minimum core requirements 2009 Each State Party has 3 years to meet the core capacity requirements 2012 All countries have reached a minimum required level of core capacities 9

WHA 58.29: Enhancement of laboratory biosafety May 2005 Member States to: 1. review safety of labs and protocols, follow WHO guidance 2. implement specific progs, follow WHO guidance 3. enhance compliance of labs with bs guidelines 4. mobilize human and financial resources to reduce LAIs 5. cooperate with other MS to facilitate access to lab equipment 6. encourage dev of bs training progs and competency stds for lab workers WHO to: 1. play an active role 2. support other programmes and partners 3. update relevant guidelines 4. provide technical support 5. report to EB 10

IHR and biosafety can WHO certify my lab? 11

Biosafety and Laboratory Biosecurity CWA 15793:2008 Laboratory Biorisk Management Standard 16 points action plan ftp://ftp.cenorm.be/public/cwas/wokrshop31/ WHO publications Implementation 12

Six years later: Where are we now? Enhancement of laboratory biosafety May 2005 Through engagement, communication, meetings, workshops, consultations, training, coordination of global efforts by various stakeholders: 2011: 1. development / revision of legislation (e.g. Singapore / China / Canada) 2. construction / renovation of laboratories (e.g. Brazil: 12 new BSL3) 3. growing commitment to implement BRM systems (CWA15793) 4. bench worker / lab manager / regulators: shift in responsibilities 5. need for education and competency based training 13

How do biosafety and laboratory biosecurity translate into practice? 14

Strengthening biosafety and lab biosecurity programmes: 'CWA 15793: Laboratory Biorisk Management Standard' Scope of CWA 15793: To set requirements necessary to control risks associated with the handling or storage and disposal of biological agents and toxins in laboratories and facilities. PDCA! 22 March 2011 Slide 15 15

What are biorisks? How are biorisks 'managed'? Biorisk: Combination of the probability of occurrence and severity of the harm where the source of harm is a biological agents or toxins The Management of Biorisks has 3 basic components: Biorisk Assessment: what are the risks associated with specific agents, specific work, individual facilities? Biorisk Mitigation: what are the measures adopted to reduce these risks? why? how is the decision made? what are the considerations? 16 Performance: are the adopted mitigation steps giving the expected and wished results? are they valid with time? reviewed regularly?

Back to the Strategic Work Plan WHO Biosafety and Laboratory Biosecurity programme's Vision (the goal): Safe and secure handling of biological agents in the world Mission (how we reach the goal): Guide, inform, provide expertise and tools, and develop recommendations to support WHO's 193 Member States protect the health of people in and around laboratory environments, in collaboration with partners Participate and collaborate in advancing the science of biorisk management, including biosafety and laboratory biosecurity Establish a biosafety and laboratory biosecurity culture worldwide 17

'Help people help themselves' 'Stimulate local economies and capabilities' 1. Develop guidance and guidelines, web-advisories (pandemic flu) cross-cutting activities, support disease-specific programmes 2. Develop tools to help and support countries achieve their goals 3. Develop and organize Regional / sub-regional training courses 4. Develop a strategic work plan and engage the global community 5. Raise funds to sustain team and activities FUNDING RESOURCES: Regular budget: 0 International funding agencies: 100% 18

WHO's contributions to global biorisk management ONGOING ACTIVITIES: Regional Biosafety Awareness Raising Meetings for animal and public health communities (3 days) develop regional action plan for follow up Strengthen biosafety interface between animal and human health (OIE/FAO/WHO) biosafety is of mutual concern: harmonize guidance CWA 15793 Laboratory Biorisk Management Awareness Training (2 days) help countries adopt and implement the standard WHO Biorisk Management Advanced Trainer Programme (10 days) create expert trainers: associate technical knowledge to adult learning techniques 19 WHO Biorisk Management (AMP model) (3 days) address users

WHO's contributions to global biorisk management (cont'd) WHO Infectious Substances Shipping Training (2 days) help develop the regulations, support their compliance In-country project (Oman) (2 years) strengthen all hazard preparedness under IHR WHO Sustainable Laboratory Design Project low-cost refit of the lab in Lianping County, China DREAMS: CEN CWA 53 Biosafety Professional Competence education: introduce biosafety into undergraduate curriculum Appropriate use, operation and maintenance of biosafety cabinets and other equipment (planned) engineering: address global needs 20

Extended Biosafety Advisory Group (BAG) Meeting 7-9 September 2010, Montreux, Switzerland Develop a 5-year strategic work plan to coordinate global laboratory biorisk management efforts: Present the plan to: 6 WHO Regional Offices, 5 WHO biosafety CCs, OIE, FAO, 6 International Biosafety Associations, vertical WHO disease-specific programmes, other stakeholders and donor agencies Outcomes, along the following lines: 1. Enhance sustainable competencies in biosafety, laboratory biosecurity and biorisk management 2. Develop and support a framework for legislation, standards and guidelines 3. Appropriate selection, operation, and maintenance of facilities and equipment 21 4. Develop an evidence based biosafety and laboratory biosecurity information platform

Conclusions We heard it yesterday, the global needs are great There is room for many to contribute Identify global / regional / local partners to support WHO's efforts and, ultimately, countries Reduce duplication of efforts Identify areas where investment (human and financial) has most impact We certainly need support to achieve the goals and meet the expectations of countries 22

The Dream Team in Geneva Piero Kaz Neda Magdi 23

Thank you http://www.who.int/ihr/biosafety/publications/en/index.html previsanin@who.int 24